Kathleen (Kathy) Wyrwich
About Kathleen (Kathy) Wyrwich
Kathleen (Kathy) Wyrwich is the Senior Director of the Patient-Reported Outcomes Assessment Team at Bristol Myers Squibb, with over two decades of experience in endpoint development and evaluation.
Current Role at Bristol Myers Squibb
Kathleen Wyrwich is currently the Senior Director of the Patient-Reported Outcomes Assessment Team at Bristol Myers Squibb. Based in St. Louis, Missouri, she assumed this role in April 2022. Kathleen leads efforts in accurately measuring patient outcomes and understanding meaningful changes over time. Her focus is on creating significant innovations by prioritizing patient needs and developing effective, patient-centered solutions.
Previous Position at Pfizer
From 2019 to 2021, Kathleen Wyrwich served as the Senior Director at Pfizer in the Greater New York City Area for a period of two years. During her tenure, she continued her work in patient-reported outcomes, contributing to the development and evaluation of endpoints that truly matter to patients. Her experience at Pfizer reinforced her commitment to improving patient-centric assessment methodologies.
Work at Eli Lilly and Company
Kathleen Wyrwich worked as a Senior Research Advisor at Eli Lilly and Company from 2017 to 2019. Within this two-year period, she applied her expertise in health services research to evolve the understanding of patient-reported outcomes, ensuring that the voice of the patient is a critical component in product development and evaluation.
Career at Evidera
Between 2013 and 2017, Kathleen Wyrwich held multiple senior positions at Evidera, including Vice President of Research, Executive Director of the Center of Excellence, and Senior Research Leader. Based in Bethesda, Maryland, she played a pivotal role in advancing research methodologies and establishing best practices for patient-reported outcomes. Her leadership drove significant progress in measuring and understanding patient priorities.
Educational Background
Kathleen Wyrwich earned her Doctor of Philosophy (PhD) in Health Services Research from Saint Louis University. She also holds both a BS and MS in Mathematics and Statistics from Southern Illinois University Edwardsville. Her robust academic background in quantitative methods and health services research underpins her expertise in developing reliable and meaningful patient-reported outcome measures.
Leadership in Endpoint Development
With over two decades of international leadership in endpoint development and evaluation, Kathleen Wyrwich is a recognized expert in the field. She focuses on identifying and measuring outcomes that are significant to patients and collaborates effectively to find the best solutions for patient-reported outcomes. Her approach fosters innovation and enhances the relevance of clinical research to patient care.